Cargando…

Fibroblast growth factor-23 and cardiovascular disease among prevalent hemodialysis patients focusing on residual kidney function

BACKGROUND: In patients undergoing incident hemodialysis, increased fibroblast growth factor-23 (FGF-23) levels are associated with the development of cardiovascular disease (CVD), but the influence of residual kidney function (RFK) on this association is unclear. This study aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kee, Youn Kyung, Jeon, Hee Jung, Oh, Jieun, Cho, Ajin, Lee, Young-Ki, Yoon, Jong-Woo, Kim, Hyunsuk, Yoo, Tae-Hyun, Shin, Dong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368752/ https://www.ncbi.nlm.nih.gov/pubmed/37501787 http://dx.doi.org/10.3389/fendo.2023.1099975

Ejemplares similares

Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination
por: Shin, Dong Ho, et al.
Publicado: (2017)

Static intra-access pressure ratio and cardiovascular events in patients undergoing haemodialysis
por: Jeon, Hee Jung, et al.
Publicado: (2020)

The relationship between intradialytic hypotension and vascular calcification in hemodialysis patients
por: Cho, AJin, et al.
Publicado: (2017)

Hypochromic red cells as predictors of anemia in patients undergoing hemodialysis: an observational retrospective study
por: Kee, Youn Kyung, et al.
Publicado: (2021)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Role of Fibroblast Growth Factor-23 in Innate Immune Responses
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2018)

Direct and indirect effects of fibroblast growth factor 23 on the heart
por: Nakano, Toshiaki, et al.
Publicado: (2023)

High cortisol levels are associated with oxidative stress and mortality in maintenance hemodialysis patients
por: Kim, Juhee, et al.
Publicado: (2022)

Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
por: Fukumoto, Seiji
Publicado: (2018)

Seropositive rate of the anti-hepatitis A immunoglobulin G antibody in maintenance hemodialysis subjects from two hospitals in Korea
por: Kim, Hyunsuk, et al.
Publicado: (2019)

Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: A 2-year prospective cohort study
por: Park, Hayne Cho, et al.
Publicado: (2020)

Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

Korean clinical practice guidelines for preventing the transmission of infections in hemodialysis facilities
por: Park, Hayne Cho, et al.
Publicado: (2018)

The paradoxical effect of aldosterone on cardiovascular outcome in maintenance hemodialysis patients
por: Choi, Sun Ryoung, et al.
Publicado: (2022)

Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level
por: Chertok Shacham, Elena, et al.
Publicado: (2023)

Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease
por: Grigore, Teodora V., et al.
Publicado: (2023)

Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
por: Kim, Do Hyoung, et al.
Publicado: (2021)

Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria
por: Velazquez-Navarro, Jassel A, et al.
Publicado: (2022)

Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice
por: Andrukhova, Olena, et al.
Publicado: (2018)

The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis
por: Martiniakova, Monika, et al.
Publicado: (2023)

Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis
por: Ma, Tian-Liang, et al.
Publicado: (2022)

Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis
por: Nishizawa, Yoko, et al.
Publicado: (2020)

Fibroblast growth factor-23 levels in maintenance hemodialysis patients in India
por: Anandh, U., et al.
Publicado: (2017)

Effects of aspirin resistance and mean platelet volume on vascular access failure in hemodialysis patients
por: Cho, AJin, et al.
Publicado: (2019)

FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018)

Corrigendum: FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018)

Direct oral anti-Xa anticoagulants versus warfarin in newly diagnosed atrial fibrillation and CKD: the Korean National Health Insurance Data
por: Kee, Youn Kyung, et al.
Publicado: (2023)

Sarcopenia and osteosarcopenia among patients undergoing hemodialysis
por: Xiang, Ting, et al.
Publicado: (2023)

Obstetric, Neonatal, and Clinical Outcomes of Day 6 vs. Day 5 Vitrified-Warmed Blastocyst Transfers: Retrospective Cohort Study With Propensity Score Matching
por: Park, Dong Soo, et al.
Publicado: (2020)

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
por: Xiao, Mengjie, et al.
Publicado: (2021)

Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis
por: Yan, Bing, et al.
Publicado: (2023)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019)

Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation
por: Kawabata, Chiaki, et al.
Publicado: (2019)

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis
por: Wolf, Myles, et al.
Publicado: (2019)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023)

Dyschloremia is associated with failure to restore renal function in survivors with acute kidney injury: an observation retrospective study
por: Kee, Youn Kyung, et al.
Publicado: (2020)

Effect of patient solicitation on mortality among patients receiving hemodialysis in Korea
por: Lee, Young-Ki, et al.
Publicado: (2019)

Changes in bioimpedance analysis components before and after hemodialysis
por: Kim, Hyunsuk, et al.
Publicado: (2018)

Paracrine Effects of FGF23 on the Heart
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sobc9ssujiqm60gjtuvmf1nj39